Skip Navigation
Skip to contents
Filter

ARTICLE TYPE

PUBLICATION DATE

14 results
Display

A Case of Phagocytic Myeloma after Chemotherapy

Lee EJ, Lim J, Lee HK, Kim M, Kim Y, Han K, Kang CS, Kim G

  • KMID: 2083447
  • Korean J Hematol.
  • 2002 May;37(2):161-163.
Hemophagocytosis by myeloma cells after chemotherapy is a rare phenomenon. We have experienced a case of phagocytic, IgG, Kappa type plasma cell myeloma in a 41-year-old man after chemotherapy. Phagocytosis...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Nonsecretory Multiple Myeloma associated with Immune Thrombocytopenia and Complicated by Malignant Ascites

Park HM, Kim I, Lee MH, Han JY, Kim CS

  • KMID: 2083445
  • Korean J Hematol.
  • 2002 May;37(2):153-157.
Thrombocytopenia is frequently seen in patients with multiple myeloma when most often the etiology is either chemotherapy induced marrow suppression or bone marrow replacement by myeloma cells. But immune thrombocytopenia...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Congenital Factor XIII Deficiency Diagnosed by Semiquantitative Method

Park JE, Yang SE, Chi HS

  • KMID: 2083448
  • Korean J Hematol.
  • 2002 May;37(2):164-167.
Factor XIII (fibrin stabilizing factor) has roles of stabilizing clot and cross-linking fibrin polymer, so the congenital factor XIII deficient patient has clot unstability and delayed bleeding episodes. We experienced...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Amylase-Producing IgG Kappa Type Multiple Myeloma

Kim KC, Lee HS, Jang YS, Lee WS, Son HS

  • KMID: 2083446
  • Korean J Hematol.
  • 2002 May;37(2):158-160.
Amylase-producing multiple myeloma is a rare disorder and has poor prognosis. Its characteristics are elevation of salivary type amylase, extensive extramedullary spread, extensive bone destruction, shorter survival time, and abnormal...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Acquired Amegakaryocytic Thrombocytopenia Responding to Immunosuppressive Therapy

Hwang YH, Bang SM, Hahn HS, Ahn JY, Cho EK, Shin DB, Lee JH

  • KMID: 2083444
  • Korean J Hematol.
  • 2002 May;37(2):147-152.
Acquired amegakaryocytic thrombocytopenia is a relatively rare bone marrow failure disorder characterized by severe thrombocytopenia associated with a total absence or a marked reduction in the number of bone marrow...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Bone Marrow Involvement of Hepatosplenic gamma delta-Cell Lymphoma

Lee SK, Woo HY, Park Q, Kim SH, Lee HG, Ko YH

  • KMID: 2083441
  • Korean J Hematol.
  • 2002 May;37(2):134-137.
Hepatosplenic gamma delta-cell lymphoma is a rare histologic type of peripheral T-cell lymphomas, clinically characterized by predominant involvement of liver and spleen, no or little adenopathy, and an often aggressive...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Two Cases of Intravascular Lymphomatosis

Lee SI, Kim WS, Lee J, Song SY, Park JO, Kim K, Jung CW, Im YH, Kang WK, Lee HG, Kwon OJ, Sung KW, Koo HH, Ko YH, Yoon SS, Park K

  • KMID: 2083442
  • Korean J Hematol.
  • 2002 May;37(2):138-142.
Intravascular lymphomatosis is a rare lymphoma characterized by neoplastic proliferation of malignant cells within the lumen of small blood vessels, usually presenting in the central nervous system or on the...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Nonmyeloablative Stem Cell Transplantation in a Patient with Refractory Acute Myeolgeous Leukemia with Central Diabetes Insipidus

Kim YS, Kim I, Park HM, Lee MH, Kim CS

  • KMID: 2083443
  • Korean J Hematol.
  • 2002 May;37(2):143-146.
A 31-year-old man presented fatigue, polydipsia and polyuria. He was diagnosed as acute myelogenous leukemia (AML) FAB-M1, and a water deprivation test confirmed central diabetes insipidus (DI). A sella magnetic...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Safety and Pharmacokinetics of Intravenous Busulfan as Conditioning prior to Allogeneic Stem Cell Transplantation

Park YH, Lee S, Kim YJ, Lee DG, Park CY, Shin HJ, Kim HJ, Min CK, Kim DW, Lee JW, Min WS, Kim CC

  • KMID: 2083440
  • Korean J Hematol.
  • 2002 May;37(2):127-133.
BACKGROUND: The unpredictable intestinal absorption and bioavailability of oral busulfan (BU) has limited the drug's use in high-dose pretransplant conditioning therapy. To overcome these problems, several trials for the evaluation...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Clinical Significance of the Chromosomal Abnormalities and Immunophenotype in Acute Myeloid Leukemia

Kwon HC

  • KMID: 2083435
  • Korean J Hematol.
  • 2002 May;37(2):89-96.
BACKGROUND: Acute myeloid leukemia (AML) is a hematologic malignant disease characterized by an uncontrolled proliferation of myeloid cells in marrow and arrest in their maturation. Immunophenotyping is a widely used...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Risk Factors of Hemorrhagic Cystitis after Allogeneic Stem Cell Transplantation

Shin HJ, Lee JW, Park CY, Park YH, Kim YJ, Lee S, Min CK, Kim HJ, Kim DW, Min WS, Kim CC

  • KMID: 2083439
  • Korean J Hematol.
  • 2002 May;37(2):120-126.
BACKGROUND: Hemorrhagic cystitis (HC) is one of major causes of morbidity during hematopoietic stem cell transplantation (HSCT), occurring in 7~52% of transplant recipients. We have analyzed the incidence, risk factors,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Treatment of Adult Acute Myelogenous Leukemia with AD Induction Therapy Followed by Consolidation Therapy with Intermediate Dose Ara-C; Long Term Follow-up Results

Lee DH, Bang SM, Jung JY, Ahn JS, Jung CW, Jung KH, Yoon SS, Oh MD, Park S, Kim BK, Choe KW, Cho HI, Kim NK

  • KMID: 2083436
  • Korean J Hematol.
  • 2002 May;37(2):97-105.
BACKGROUND: This study was to evaluate the therapeutic efficacy of consolidation therapy based on intermediate dose Ara-C in patients with newly diagnosed acute myelogenous leukemia (AML) in Seoul National University...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Hematopoietic Stem Cell Transplantation for Paroxysmal Nocturnal Hemoglobinuria

Shin HJ, Kim HJ, Park CY, Park YH, Kim YJ, Lee S, Min CK, Kim DW, Lee JW, Kim CC, Min WS

  • KMID: 2083438
  • Korean J Hematol.
  • 2002 May;37(2):114-119.
BACKGROUND: Paroxysmal nocturnal hemogolbinuria (PNH) is an acquired clonal hematological disorder characterized by intermittent episodes of hemolysis, a predisposition to venous thrombosis, defective hemopoiesis, and occasionally, transition to leukemia. Because...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Allogeneic Hematopoietic Stem Cell Transplantation Using Intensified Conditioning Regimen and High dose Stem Cells in Severe Aplastic Anemia

Park CY, Min WS, Shin HJ, Kim YJ, Park YH, Kim HJ, Lee S, Min CK, Kim DW, Lee JW, Park JW, Kim CC

  • KMID: 2083437
  • Korean J Hematol.
  • 2002 May;37(2):106-113.
BACKGROUND: Graft rejection as well as graft versus host disease is the main cause of failure after allogeneic hematopoietic stem cell transplantation (HSCT) in patient with severe aplastic anemia. Graft...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr